Morgan Stanley Reduces PT on Tenaya Therapeutics (TNYA), Keeps Constructive Stance on U.S. Small- to Mid-Cap Biotech

Tenaya Therapeutics, Inc. (NASDAQ:TNYA) is one of the stocks under $1 that will explode. Morgan Stanley Reduces PT on Tenaya Therapeutics (TNYA), Keeps Constructive Stance on U.S. Small- to Mid-Cap Biotech Chaikom/Shutterstock.com On January 8, 2026, TheFly reported that Morgan Stanley reduced its price target on Tenaya Therapeutics, Inc. (NASDAQ:TNYA) from $5 to $2, while reiterating an ‘Overweight’ rating. The firm keeps its constructive stance on U.S. small- to mid-cap biotech in 2026, as it expects ...